Item Type | Name |
Academic Article
|
Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
|
Academic Article
|
WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.
|
Academic Article
|
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
|
Academic Article
|
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.
|
Academic Article
|
Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
|
Academic Article
|
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.
|
Academic Article
|
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
|
Academic Article
|
The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.
|
Academic Article
|
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
|
Academic Article
|
Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells.
|
Academic Article
|
Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor.
|
Academic Article
|
Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium.
|
Academic Article
|
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.
|
Academic Article
|
Exploratory analysis of the copy number alterations in glioblastoma multiforme.
|
Academic Article
|
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.
|
Concept
|
Transgenes
|
Concept
|
DNA, Recombinant
|
Concept
|
Genes, Reporter
|
Concept
|
Gene Expression Regulation, Enzymologic
|
Concept
|
Gene Expression Profiling
|
Concept
|
Regulatory Elements, Transcriptional
|
Concept
|
src Homology Domains
|
Concept
|
Genes, erbB-2
|
Concept
|
Gene Amplification
|
Concept
|
Gene Regulatory Networks
|
Concept
|
Multigene Family
|
Concept
|
Genes, BRCA1
|
Concept
|
Genes, Tumor Suppressor
|
Concept
|
Oncogenes
|
Concept
|
Epistasis, Genetic
|
Concept
|
Gene Expression
|
Concept
|
Genes
|
Concept
|
Amino Acid Sequence
|
Concept
|
Genes, Dominant
|
Concept
|
Catalytic Domain
|
Concept
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
|
Concept
|
Gene Order
|
Concept
|
Genes, p16
|
Concept
|
Genome, Human
|
Concept
|
Proto-Oncogenes
|
Concept
|
Gene Fusion
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Gene Library
|
Concept
|
Genes, myc
|
Concept
|
Gene Expression Regulation, Neoplastic
|
Concept
|
Sequence Homology, Amino Acid
|
Concept
|
Sequence Homology, Nucleic Acid
|
Concept
|
Genes, BRCA2
|
Concept
|
Genome
|
Concept
|
Genes, jun
|
Concept
|
Molecular Structure
|
Concept
|
Gene Frequency
|
Concept
|
Antilymphocyte Serum
|
Concept
|
Gene Deletion
|
Concept
|
Gene Silencing
|
Concept
|
Gene Duplication
|
Concept
|
Gene Knockout Techniques
|
Concept
|
Genes, erbB-1
|
Concept
|
Base Sequence
|
Concept
|
Alleles
|
Concept
|
Gene Knockdown Techniques
|
Concept
|
Genes, Homeobox
|
Concept
|
Gene Transfer Techniques
|
Concept
|
Molecular Sequence Data
|
Concept
|
Gene Expression Regulation, Developmental
|
Concept
|
Genes, Retinoblastoma
|
Concept
|
Conserved Sequence
|
Concept
|
Genes, ras
|
Concept
|
Gene Expression Regulation
|
Concept
|
Consensus Sequence
|
Concept
|
Genes, Neoplasm
|
Concept
|
Genes, p53
|
Concept
|
Nucleic Acid Conformation
|
Concept
|
Gene Dosage
|
Academic Article
|
Comprehensive molecular characterization of clear cell renal cell carcinoma.
|
Academic Article
|
The Cancer Genome Atlas Pan-Cancer analysis project.
|
Academic Article
|
The somatic genomic landscape of glioblastoma.
|
Academic Article
|
A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes.
|
Academic Article
|
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.
|
Academic Article
|
Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells.
|
Academic Article
|
Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer.
|
Academic Article
|
Comprehensive molecular characterization of urothelial bladder carcinoma.
|
Academic Article
|
Integrated genomic analyses of ovarian carcinoma.
|
Academic Article
|
Molecular characterization of gallbladder cancer using somatic mutation profiling.
|
Academic Article
|
Genome-wide transcriptome profiling of homologous recombination DNA repair.
|
Academic Article
|
Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules.
|
Academic Article
|
Unraveling the regulatory connections between two controllers of breast cancer cell fate.
|
Academic Article
|
Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels.
|
Academic Article
|
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.
|
Academic Article
|
Definition of PKC-a, CDK6, and MET as therapeutic targets in triple-negative breast cancer.
|
Academic Article
|
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.
|
Academic Article
|
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.
|
Academic Article
|
Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks.
|
Academic Article
|
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.
|
Academic Article
|
Functional consequence of the MET-T1010I polymorphism in breast cancer.
|
Academic Article
|
Identification, cloning, and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q.
|
Academic Article
|
Bead transfection: rapid and efficient gene transfer into marrow stromal and other adherent mammalian cells.
|
Academic Article
|
Human hematopoietic cell express two forms of the cytokine receptor common gamma-chain (gamma c).
|
Academic Article
|
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
|
Academic Article
|
Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus.
|
Academic Article
|
Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway.
|
Academic Article
|
Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
|
Academic Article
|
Determinants of rapamycin sensitivity in breast cancer cells.
|
Academic Article
|
Analysis of molecular aberrations in ovarian cancer allows novel target identification.
|
Academic Article
|
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
|
Academic Article
|
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.
|
Academic Article
|
Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling.
|
Academic Article
|
A module of negative feedback regulators defines growth factor signaling.
|
Academic Article
|
Acquired resistance to erlotinib in A-431 epidermoid cancer cells requires down-regulation of MMAC1/PTEN and up-regulation of phosphorylated Akt.
|
Academic Article
|
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
|
Academic Article
|
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells.
|
Academic Article
|
Cetuximab attenuates metastasis and u-PAR expression in non-small cell lung cancer: u-PAR and E-cadherin are novel biomarkers of cetuximab sensitivity.
|
Academic Article
|
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
|
Academic Article
|
Gene and protein expression markers of response to combined antiangiogenic and epidermal growth factor targeted therapy in renal cell carcinoma.
|
Academic Article
|
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.
|
Academic Article
|
ERa-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer.
|
Academic Article
|
Androgen regulation of 5a-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention.
|
Academic Article
|
An emerging toolkit for targeted cancer therapies.
|
Academic Article
|
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
|
Academic Article
|
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.
|
Academic Article
|
Mechanistic basis for overcoming platinum resistance using copper chelating agents.
|
Academic Article
|
Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy.
|
Academic Article
|
Rab25 in cancer: a brief update.
|
Academic Article
|
Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia.
|
Academic Article
|
Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.
|
Academic Article
|
Modeling precision treatment of breast cancer.
|
Academic Article
|
Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes.
|
Academic Article
|
Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.
|
Academic Article
|
Expression of TTK, a novel human protein kinase, is associated with cell proliferation.
|
Academic Article
|
Activation of phospholipase C in human B cells is dependent on tyrosine phosphorylation.
|
Academic Article
|
Expression of ras oncogene leads to down-regulation of protein kinase C.
|
Academic Article
|
Inhibition of stimulus-dependent epidermal growth factor receptor and transforming growth factor-alpha mRNA accumulation by the protein kinase C inhibitor staurosporine.
|
Academic Article
|
The cell biology of ras-induced transformation: insights from studies utilizing an inducible hybrid oncogene system.
|
Academic Article
|
Comparison of phorbol ester/calcium ionophore and phytohemagglutinin-induced signaling in human T lymphocytes. Demonstration of interleukin 2-independent transferrin receptor gene expression.
|
Academic Article
|
pp60c-src expression is induced by activation of normal human T lymphocytes.
|
Academic Article
|
HLA-G expression during preimplantation human embryo development.
|
Academic Article
|
Expression of p16 induces transcriptional downregulation of the RB gene.
|
Academic Article
|
p202 prevents apoptosis in murine AKR-2B fibroblasts.
|
Academic Article
|
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
|
Academic Article
|
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas.
|
Academic Article
|
Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
|
Academic Article
|
Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.
|
Academic Article
|
Genetic analysis of early- versus late-stage ovarian tumors.
|
Academic Article
|
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
|
Academic Article
|
ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.
|
Academic Article
|
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
|
Academic Article
|
Molecular therapeutics: promise and challenges.
|
Academic Article
|
Stem cell-ness: a "magic marker" for cancer.
|
Academic Article
|
Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.
|
Academic Article
|
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
|
Academic Article
|
Bayesian models based on test statistics for multiple hypothesis testing problems.
|
Academic Article
|
Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer.
|
Academic Article
|
A sequence-based survey of the complex structural organization of tumor genomes.
|
Academic Article
|
Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha.
|
Academic Article
|
Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance.
|
Academic Article
|
Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
|
Academic Article
|
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
|
Academic Article
|
Genomic amplicons target vesicle recycling in breast cancer.
|
Academic Article
|
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.
|
Academic Article
|
Ras-superfamily GTP-ases in ovarian cancer.
|
Academic Article
|
Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer.
|
Academic Article
|
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.
|
Academic Article
|
Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy.
|
Academic Article
|
MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells.
|
Academic Article
|
HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.
|
Academic Article
|
Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.
|
Academic Article
|
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.
|
Academic Article
|
Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.
|
Academic Article
|
Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing.
|
Academic Article
|
Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis.
|
Academic Article
|
Integrated genomic characterization of endometrial carcinoma.
|
Academic Article
|
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer.
|
Academic Article
|
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.
|
Academic Article
|
An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation.
|
Academic Article
|
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer.
|
Academic Article
|
Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
|
Academic Article
|
Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.
|
Academic Article
|
Comprehensive molecular profiling of lung adenocarcinoma.
|
Academic Article
|
T-lymphocyte proliferation: tyrosine kinases in interleukin 2 signal transduction.
|
Academic Article
|
Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cells.
|
Academic Article
|
Activation of the Na+/H+ antiport is not required for epidermal growth factor-dependent gene expression, growth inhibition or proliferation in human breast cancer cells.
|
Academic Article
|
Induction of competence and progression signals in human T lymphocytes by phorbol esters and calcium ionophores.
|
Academic Article
|
Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma.
|
Academic Article
|
Genomic components of carcinogenesis.
|
Academic Article
|
Molecular characterization of hNRP, a cDNA encoding a human nucleosome-assembly-protein-I-related gene product involved in the induction of cell proliferation.
|
Academic Article
|
Cell cycle dependent regulation of the protein kinase TTK.
|
Academic Article
|
Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity.
|
Academic Article
|
Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status.
|
Academic Article
|
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
|
Academic Article
|
Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase.
|
Academic Article
|
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
|
Academic Article
|
Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics.
|
Academic Article
|
The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy.
|
Academic Article
|
Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
|
Academic Article
|
Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.
|
Academic Article
|
Expression of endogenous granzyme B in a subset of human primary breast carcinomas.
|
Academic Article
|
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust.
|
Academic Article
|
A genetically defined model for human ovarian cancer.
|
Academic Article
|
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.
|
Academic Article
|
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.
|
Academic Article
|
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
|
Academic Article
|
A new mutational AKTivation in the PI3K pathway.
|
Academic Article
|
Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.
|
Academic Article
|
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
|
Academic Article
|
Homozygous deletion of glycogen synthase kinase 3beta bypasses senescence allowing Ras transformation of primary murine fibroblasts.
|
Academic Article
|
A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.
|
Academic Article
|
A systems approach to analysis of molecular complexity in breast cancer.
|
Academic Article
|
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
|
Academic Article
|
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
|
Academic Article
|
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1.
|
Academic Article
|
Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase.
|
Academic Article
|
Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.
|
Academic Article
|
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer.
|
Academic Article
|
Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid.
|
Academic Article
|
Personalizing therapy for ovarian cancer: BRCAness and beyond.
|
Academic Article
|
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.
|
Academic Article
|
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer.
|
Academic Article
|
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
|
Academic Article
|
A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance.
|
Academic Article
|
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.
|
Academic Article
|
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling.
|
Academic Article
|
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms.
|
Academic Article
|
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.
|
Academic Article
|
Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR.
|
Academic Article
|
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancer.
|
Academic Article
|
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.
|
Academic Article
|
Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells.
|
Academic Article
|
Development and validation of a prognostic gene-expression signature for lung adenocarcinoma.
|
Academic Article
|
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.
|
Academic Article
|
Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.
|
Academic Article
|
Mask is required for the activity of the Hippo pathway effector Yki/YAP.
|
Academic Article
|
EVI1 splice variants modulate functional responses in ovarian cancer cells.
|
Academic Article
|
Inferring tumour purity and stromal and immune cell admixture from expression data.
|
Academic Article
|
A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer.
|
Academic Article
|
Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B, PTP-alpha expression.
|
Academic Article
|
Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
|
Academic Article
|
The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
|
Academic Article
|
Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer.
|
Academic Article
|
Specific keynote: genome copy number abnormalities in ovarian cancer.
|
Academic Article
|
Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signaling.
|
Academic Article
|
Non-parametric quantification of protein lysate arrays.
|
Academic Article
|
Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation.
|
Academic Article
|
Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
|
Academic Article
|
PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
|
Academic Article
|
Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers.
|
Academic Article
|
A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
|
Academic Article
|
DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.
|
Academic Article
|
Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.
|
Academic Article
|
Systematic analysis of genotype-specific drug responses in cancer.
|
Academic Article
|
Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice.
|
Academic Article
|
Network inference using steady-state data and Goldbeter-Koshland kinetics. [corrected].
|
Academic Article
|
Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCa invasive signaling axis.
|
Academic Article
|
Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
|
Academic Article
|
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin.
|
Academic Article
|
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
|
Academic Article
|
Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines.
|
Academic Article
|
Exploiting the PI3K/AKT pathway for cancer drug discovery.
|
Academic Article
|
Assessing BRCA carrier probabilities in extended families.
|
Academic Article
|
Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer.
|
Academic Article
|
Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.
|
Academic Article
|
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer.
|
Academic Article
|
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
|
Academic Article
|
Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.
|
Academic Article
|
Subtype and pathway specific responses to anticancer compounds in breast cancer.
|
Academic Article
|
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins.
|
Academic Article
|
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
|
Academic Article
|
Alterations in oncogenes, tumor suppressor genes, and growth factors associated with epithelial ovarian cancers.
|
Academic Article
|
Regulation of mRNA expression in breast cancer - a cis-tematic trans-action.
|
Academic Article
|
Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer.
|
Academic Article
|
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.
|
Academic Article
|
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation.
|
Academic Article
|
Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
|
Academic Article
|
Concordance of genomic alterations between primary and recurrent breast cancer.
|
Academic Article
|
YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.
|
Academic Article
|
A pan-cancer proteomic perspective on The Cancer Genome Atlas.
|
Academic Article
|
AKT pathway genes define 5 prognostic subgroups in glioblastoma.
|
Academic Article
|
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.
|
Academic Article
|
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
|
Academic Article
|
hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness.
|
Academic Article
|
Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions.
|
Academic Article
|
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1a and oxidative phosphorylation in melanoma.
|
Academic Article
|
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.
|
Academic Article
|
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
|
Academic Article
|
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.
|
Academic Article
|
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
|
Academic Article
|
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.
|
Academic Article
|
A decision support framework for genomically informed investigational cancer therapy.
|
Academic Article
|
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2.
|
Academic Article
|
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.
|
Academic Article
|
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.
|
Academic Article
|
Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
|
Academic Article
|
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.
|
Academic Article
|
Retrospective Review of MET Gene Mutations.
|
Academic Article
|
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
|
Academic Article
|
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
|
Academic Article
|
Regulation of the PI3K pathway through a p85a monomer-homodimer equilibrium.
|
Academic Article
|
Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance.
|
Academic Article
|
Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.
|
Academic Article
|
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
|
Academic Article
|
Robust Selection Algorithm (RSA) for Multi-Omic Biomarker Discovery; Integration with Functional Network Analysis to Identify miRNA Regulated Pathways in Multiple Cancers.
|
Academic Article
|
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance.
|
Academic Article
|
mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer.
|
Academic Article
|
Functional annotation of rare gene aberration drivers of pancreatic cancer.
|
Academic Article
|
Inferring causal molecular networks: empirical assessment through a community-based effort.
|
Academic Article
|
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.
|
Academic Article
|
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
|
Academic Article
|
Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.
|
Academic Article
|
Multiplatform-based molecular subtypes of non-small-cell lung cancer.
|
Academic Article
|
Functional annotation of rare gene aberration drivers of pancreatic cancer
|
Academic Article
|
Association of somatic mutations of ADAMTS genes with chemotherapy sensitivity and survival in high-grade serous ovarian carcinoma
|
Academic Article
|
Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects
|
Academic Article
|
Retrospective review of MET gene mutations
|
Academic Article
|
Messenger rna expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysis
|
Academic Article
|
068 Isolation of a possible human counterpart to the murine XLR genes
|
Academic Article
|
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
|
Academic Article
|
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
|
Academic Article
|
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of Cancer.
|
Academic Article
|
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.
|
Academic Article
|
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers.
|
Academic Article
|
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.
|
Academic Article
|
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
|
Academic Article
|
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
|
Academic Article
|
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
|
Academic Article
|
Comprehensive Characterization of Cancer Driver Genes and Mutations.
|
Academic Article
|
A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.
|
Academic Article
|
Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype.
|
Academic Article
|
Messenger RNA expression and methylation of candidate tumor-suppressor genes and risk of ovarian cancer-a case-control analysis.
|
Academic Article
|
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.
|
Academic Article
|
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer.
|
Academic Article
|
PKCiota promotes ovarian tumor progression through deregulation of cyclin E.
|
Academic Article
|
Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer.
|
Academic Article
|
Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.
|
Academic Article
|
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
|
Academic Article
|
Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies.
|
Academic Article
|
The ErbB2?Ex16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment.
|
Academic Article
|
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.
|
Academic Article
|
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.
|
Academic Article
|
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
|
Academic Article
|
Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.
|
Academic Article
|
AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
|
Academic Article
|
Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes.
|
Academic Article
|
HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors.
|
Academic Article
|
High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype.
|
Academic Article
|
Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.
|
Academic Article
|
Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
|
Academic Article
|
Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p.
|
Academic Article
|
Clinical outcomes based on multigene profiling in metastatic breast cancer patients.
|
Academic Article
|
Loss-of-function screens of druggable targetome against cancer stem-like cells.
|
Academic Article
|
Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
|
Academic Article
|
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
|
Academic Article
|
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
|
Academic Article
|
Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer.
|
Academic Article
|
Functional variomics and network perturbation: connecting genotype to phenotype in cancer.
|
Academic Article
|
Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data Sets.
|
Academic Article
|
Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm.
|
Academic Article
|
Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-?B Pathway in Melanoma.
|
Academic Article
|
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer.
|
Academic Article
|
Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
|
Academic Article
|
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer.
|
Academic Article
|
Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
|
Academic Article
|
Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.
|
Academic Article
|
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.
|
Academic Article
|
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
|
Academic Article
|
ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.
|
Academic Article
|
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.
|
Academic Article
|
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes.
|
Academic Article
|
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers.
|
Academic Article
|
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
|
Academic Article
|
Rab25 augments cancer cell invasiveness through a ?1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.
|
Academic Article
|
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.
|
Academic Article
|
BRD4 facilitates replication stress-induced DNA damage response.
|
Academic Article
|
Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3p.
|
Academic Article
|
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
|
Academic Article
|
Modulation of the Hippo pathway and organ growth by RNA processing proteins.
|
Academic Article
|
Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance.
|
Academic Article
|
?-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer.
|
Academic Article
|
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors.
|
Academic Article
|
Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer.
|
Academic Article
|
Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation.
|
Academic Article
|
Comprehensive Characterization of Cancer Driver Genes and Mutations.
|
Academic Article
|
MERIT: Systematic Analysis and Characterization of Mutational Effect on RNA Interactome Topology.
|
Academic Article
|
Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models.
|
Academic Article
|
PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness.
|
Academic Article
|
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
|
Academic Article
|
PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.
|
Academic Article
|
Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness.
|
Academic Article
|
GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and ?-catenin activity.
|
Academic Article
|
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer.
|
Academic Article
|
Breast cancer quantitative proteome and proteogenomic landscape.
|
Academic Article
|
Integrated transcriptomic-genomic tool Texomer profiles cancer tissues.
|
Academic Article
|
Next-generation characterization of the Cancer Cell Line Encyclopedia.
|
Concept
|
Gene Editing
|
Concept
|
Transcriptome
|
Concept
|
Exome
|
Concept
|
Gene Ontology
|
Academic Article
|
The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric Cancer.
|
Academic Article
|
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling.
|
Academic Article
|
COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.
|
Academic Article
|
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases.
|
Academic Article
|
Comprehensive characterization of circular RNAs in ~?1000 human cancer cell lines.
|
Academic Article
|
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming.
|
Academic Article
|
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
|
Academic Article
|
Proteomics advances for precision therapy in ovarian cancer.
|
Academic Article
|
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
|
Academic Article
|
MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis.
|
Academic Article
|
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
|
Academic Article
|
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.
|
Academic Article
|
Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer.
|
Academic Article
|
p85? regulates autophagic degradation of AXL to activate oncogenic signaling.
|
Academic Article
|
MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling.
|
Academic Article
|
Multiplex digital spatial profiling of proteins and RNA in fixed tissue.
|
Academic Article
|
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models.
|
Academic Article
|
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
|
Academic Article
|
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma.
|
Academic Article
|
Integrated Genomic Characterization of the Human Immunome in Cancer.
|
Academic Article
|
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.
|
Academic Article
|
Transient commensal clonal interactions can drive tumor metastasis.
|
Academic Article
|
Hormonal modulation of ESR1 mutant metastasis.
|
Academic Article
|
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.
|
Academic Article
|
MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors.
|
Academic Article
|
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer.
|
Academic Article
|
mi-IsoNet: systems-scale microRNA landscape reveals rampant isoform-mediated gain of target interaction diversity and signaling specificity.
|
Academic Article
|
Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers.
|
Academic Article
|
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.
|
Academic Article
|
CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models.
|
Academic Article
|
BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators.
|
Academic Article
|
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway.
|
Academic Article
|
A functional genomic approach to actionable gene fusions for precision oncology.
|
Academic Article
|
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.
|
Academic Article
|
Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer.
|
Academic Article
|
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma.
|